The Role of NKT Cells in Glioblastoma

The Role of NKT Cells in Glioblastoma

Glioblastoma is an aggressive and deadly cancer, but to date, immunotherapies have failed to make significant strides in improving prognoses for glioblastoma patients. One of the current challenges to developing immunological interventions for glioblastoma is our incomplete understanding of the nume...

Full description

Bibliographic Details
Main Authors:	Emily E. S. Brettschneider, Masaki Terabe
Format:	Article
Language:	English
Published:	MDPI AG 2021-06-01
Series:	Cells
Subjects:	glioblastoma natural killer T cell (NKT) lipid antigen brain tumor tumor immunity glioma
Online Access:	https://www.mdpi.com/2073-4409/10/7/1641

Similar Items

Tissue-Specific Roles of NKT Cells in Tumor Immunity
by: Masaki Terabe, et al.
Published: (2018-08-01)

Altered Lipid Tumor Environment and Its Potential Effects on NKT Cell Function in Tumor Immunity
by: Shweta Tiwary, et al.
Published: (2019-09-01)

NKT cell networks in the regulation of tumor immunity
by: Faith C Robertson, et al.
Published: (2014-10-01)

Making a Cold Tumor Hot: The Role of Vaccines in the Treatment of Glioblastoma
by: Stephen C. Frederico, et al.
Published: (2021-05-01)

Tissue-specific shaping of the TCR repertoire and antigen specificity of iNKT cells
by: Rebeca Jimeno, et al.
Published: (2019-12-01)

Current management of glioblastoma multiforme
by: Moscote-Salazar Luís Rafael, et al.
Published: (2010-12-01)

NK Cell-Based Glioblastoma Immunotherapy
by: Irene Golán, et al.
Published: (2018-12-01)

Targeting and Therapy of Glioblastoma in a Mouse Model Using Exosomes Derived From Natural Killer Cells
by: Liya Zhu, et al.
Published: (2018-04-01)

NKT Cells in Neurological Diseases
by: Yu Cui, et al.
Published: (2019-05-01)

Role of NKT Cells during Viral Infection and the Development of NKT Cell-Based Nanovaccines
by: Masood Alam Khan, et al.
Published: (2021-08-01)

Possible Therapeutic Application of Targeting Type II Natural Killer T Cell-Mediated Suppression of Tumor Immunity
by: Shingo Kato, et al.
Published: (2018-02-01)

NK/NKT Cells and Aging
by: Yu-Jen Chen, et al.
Published: (2007-06-01)

NKT Cells Contribute to the Control of Microbial Infections
by: Stefan Vogt, et al.
Published: (2021-09-01)

Temozolomide lymphodepletion enhances CAR abundance and correlates with antitumor efficacy against established glioblastoma
by: Carter M. Suryadevara, et al.
Published: (2018-06-01)

Regorafenib in Recurrent Glioblastoma Patients: A Large and Monocentric Real-Life Study
by: Giuseppe Lombardi, et al.
Published: (2021-09-01)

Enhancing Neuroblastoma Immunotherapies by Engaging iNKT and NK Cells
by: Kevin O. McNerney, et al.
Published: (2020-05-01)

Glioblastoma Organoids: Pre-Clinical Applications and Challenges in the Context of Immunotherapy
by: Eliane Klein, et al.
Published: (2020-12-01)

Tumor-Specific T Cell Activation in Malignant Brain Tumors
by: Malte Mohme, et al.
Published: (2020-02-01)

Chimeric Antigen Receptor T-Cell Therapy in Glioblastoma: Current and Future
by: Long Li, et al.
Published: (2020-11-01)

NK and NKT cells in the diagnosis of diffuse lung diseases presenting with a lymphocytic alveolitis
by: Oksana Sokhatska, et al.
Published: (2019-02-01)

A Review of Newly Diagnosed Glioblastoma
by: Bryan Oronsky, et al.
Published: (2021-02-01)

In vitro evidence for glioblastoma cell death in temperatures found in the penumbra of laser-ablated tumors
by: Joshua D. Frenster, et al.
Published: (2020-07-01)

A brief review of clinical trials involving manipulation of invariant NKT cells as a promising approach in future cancer therapies
by: Małgorzata Waldowska, et al.
Published: (2017-08-01)

Radiation-Induced Changes in Tumor Vessels and Microenvironment Contribute to Therapeutic Resistance in Glioblastoma
by: Yun-Soo Seo, et al.
Published: (2019-11-01)

5-ALA Fluorescence Image Guided Resection of Glioblastoma Multiforme: A Meta-Analysis of the Literature
by: Samy Eljamel
Published: (2015-05-01)

Comparison of Circulating NKT Cells Numbers in Multi Drug Resistant Tuberculosis Patients and Healthy Subjects Using Tuberculin Skin Test
by: A Zavaran-Hoseeni, et al.
Published: (2009-07-01)

Micro RNA Molecules as Modulators of Treatment Resistance, Immune Checkpoints Controllers and Sensitive Biomarkers in Glioblastoma Multiforme
by: Marek Mazurek, et al.
Published: (2020-02-01)

Role of natural killer cells in isocitrate dehydrogenase 1/2 mutant glioma pathogenesis and emerging therapies
by: Xiaoran Zhang, et al.
Published: (2019-01-01)

Natural Killer T-Cell Agonist α-Galactosylceramide and PD-1 Blockade Synergize to Reduce Tumor Development in a Preclinical Model of Colon Cancer
by: Ying Wang, et al.
Published: (2020-10-01)

Unraveling Natural Killer T-Cells Development
by: Sabrina Bianca Bennstein
Published: (2018-01-01)

NK, NKT and Invariant-NKT Cells in Tumor Draining Lymph Nodes of Patients with Breast Cancer
by: Somayeh Rezaeifard, et al.
Published: (2019-12-01)

Combination of NKT14m and Low Dose IL-12 Promotes Invariant Natural Killer T Cell IFN-γ Production and Tumor Control
by: Peng Guan, et al.
Published: (2020-07-01)

Hiding Lipid Presentation: Viral Interference with CD1d-Restricted Invariant Natural Killer T (iNKT) Cell Activation
by: Maaike E. Ressing, et al.
Published: (2012-10-01)

CAR-NK Cell: A New Paradigm in Tumor Immunotherapy
by: Faroogh Marofi, et al.
Published: (2021-06-01)

Promotion or Suppression of Murine Intestinal Polyp Development by iNKT Cell Directed Immunotherapy
by: Ying Wang, et al.
Published: (2019-03-01)

The Role of Natural Killer Cells in the Context of Oncolytic Herpes Simplex Virotherapy for Glioblastoma
by: Alvarez-Breckenridge, Christopher
Published: (2011)

Microglia-Centered Combinatorial Strategies Against Glioblastoma
by: Tomás A. Martins, et al.
Published: (2020-09-01)

Molecular Heterogeneity and Immunosuppressive Microenvironment in Glioblastoma
by: Syreeta DeCordova, et al.
Published: (2020-07-01)

Harnessing the Power of Invariant Natural Killer T Cells in Cancer Immunotherapy
by: Melissa Bedard, et al.
Published: (2017-12-01)

Modulation of Immune Responses to Influenza A Virus Vaccines by Natural Killer T Cells
by: John P. Driver, et al.
Published: (2020-10-01)